Etofylline clofibrate has a hypolipidemic and antithrombotic effect and it also has an agonistic interaction with intimal PGI2.

Etofylline clofibrate (p.o.; 12 mg/kg) has the moderate effect of a single dose (12% reduction in disaggregation time). It has a maximum reduction of 31 and 43% following 5 and 7 consecutive daily applications, respectively.

54504-70-0

C19H21ClN4O5

420.85

Etofylline clofibrate

DMSO:52 mg/mL (123.56 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years